Complete suite of IHC testing for key biomarkers in all solid tumors, including c-MET, now available in addition to Guardant360 Tissue multiomic profiling test PALO ALTO, Calif.--(BUSINESS WIRE)-- ...

The clinical application of PD-L1 immunohistochemistry (IHC) testing is complicated by the availability of multiple IHC assays, scoring algorithms, and cutoffs. This study assessed the analytical ...

Medically reviewed by Doru Paul, MD Key Takeaways Immunohistochemistry (IHC) is used to find specific molecules on cells with ...

Researchers from Lund University (Sweden) have investigated the tumor immune microenvironment of primary triple-negative breast cancer using digital image analysis of IHC-stained immune cells. To do ...

Assessment of Coronary Heart Disease Morbidity and Mortality After Radiation Therapy for Early Breast Cancer PURPOSE: To compare microsatellite instability (MSI) testing with immunohistochemical (IHC) ...

In early findings, the antibody drug conjugate created strong responses in multiple tumor types where patients have unmet need. Trastuzumab deruxtecan, already used in to treat patients with breast, ...

The HER2-low and HER2-ultralow breast cancer subtype designations have led to a changed landscape in HER2-directed therapies, as well as a desire for more sensitive assays that may better quantify ...

—Adopting evidence-based, unified scoring criteria specifically validated for colorectal cancer could help ensure that the right patients receive the right targeted treatment at the right time. Human ...

ALBUQUERQUE, NM / ACCESSWIRE / August 15, 2024 / Indica Labs today announces expansion of AI capabilities for life science with the launch of HALO AI Apps, pre-trained tissue classifiers and cell ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Miller: Before we ...